Patents by Inventor Gregory M. Harrowe

Gregory M. Harrowe has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120045450
    Abstract: M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.
    Type: Application
    Filed: August 23, 2011
    Publication date: February 23, 2012
    Applicant: NOVARTIS AG
    Inventors: William M. Kavanaugh, Gregory M. Harrowe, Kirston Koths, Cheng Liu, Deborah L. Zimmerman
  • Publication number: 20110091451
    Abstract: M-CSF antagonists are used to prepare compositions, including pharmaceutical compositions, for preventing or treating cancer metastasis and/or bone loss associated with cancer metastasis in a mammal.
    Type: Application
    Filed: August 9, 2004
    Publication date: April 21, 2011
    Inventors: William M. Kavanaugh, Gregory M. Harrowe, Kirston Koths, Cheng Liu, Deborah L. Zimmerman
  • Publication number: 20090324604
    Abstract: M-CSF-specific antibody RX1 is provided, along with pharmaceutical compositions containing antibody RX1, kits containing a pharmaceutical composition, and methods of preventing and treating bone loss in a subject afflicted with an osteolytic disease.
    Type: Application
    Filed: January 6, 2005
    Publication date: December 31, 2009
    Applicants: CHIRON CORPORATION, XOMA Technology Ltd.
    Inventors: Cheng Liu, Deborah Lee Zimmerman, Gregory M. Harrowe, Kirston Koths, William M. Kavanaugh, Li Long, Arnold Horwitz, Maria Calderon-Cacia